Literature DB >> 6089708

Coxsackievirus B4: in vitro genetic markers and cardiovirulence. Brief report.

S Jimes, R M Jamison, W D Grafton.   

Abstract

The relationship of cardiovirulence in mice (HAM/ICR, Swiss ND-4) of four coxsackievirus B4 strains to previously described in vitro markers (t, d, DS, DEAE-D, G, PS) has been determined. A relationship between plaque size and acardiovirulence was demonstrated in the HAM/ICR coxsackievirus B4 mouse system.

Entities:  

Mesh：

Year:  1984        PMID： 6089708     DOI： 10.1007/bf01310005

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  14 in total

1.  EXPERIMENTAL ACUTE MYOCARDITIS.

Authors:  E R RABIN; J L MELNICK
Journal:  Prog Cardiovasc Dis       Date:  1964-07       Impact factor: 8.194

2.  [Remarks on non-specific factors governing the development of viral infections; notion of the critical status].

Authors:  A LWOFF; M LWOFF
Journal:  C R Hebd Seances Acad Sci       Date:  1959-01-05

3.  The medical and public health importance of the Coxsackie viruses.

Authors:  J GEAR; V MEASROCH; F R PRINSLOO
Journal:  S Afr Med J       Date:  1956-08-25

4.  Myocarditis in newborns, caused by coxsackie virus; clinical and pathological data.

Authors:  H DE JAGER; S VAN CREVELD
Journal:  Ann Paediatr       Date:  1956 Jul-Aug

5.  Lesions induced by encephalomyocarditis virus and coxsackievirus B in newborn mice.

Authors:  G E Burch; J M Harb
Journal:  Arch Pathol Lab Med       Date:  1979-07       Impact factor: 5.534

6.  Assessment of coxsackievirus B3 ts mutants for induction of myocarditis in a murine model.

Authors:  M D Trousdale; R E Paque; T Nealon; C J Gauntt
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

7.  Coxsackievirus B4 myocarditis in mice: valvular changes in virus-infected and control animals.

Authors:  M R el-Khatib; J L Chason; K L Ho; B Silberberg; A M Lerner
Journal:  J Infect Dis       Date:  1978-04       Impact factor: 5.226

8.  Cardiac manifestations during a Coxsackie B5 epidemic.

Authors:  M Helin; J Savola; K Lapinleimu
Journal:  Br Med J       Date:  1968-07-13

9.  Serious Coxsackie infection in infants and children; myocarditis, meningoencephalitis, and hepatitis.

Authors:  D M HOSIER; W A NEWTON
Journal:  AMA J Dis Child       Date:  1958-09

10.  Coxsackievirus B4: in vitro genetic markers and virulence.

Authors:  S Jimes; R M Jamison
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.